LGMN and Alzheimer disease: Inhibition of C/EBPβ activity reduced AEP‐mediated cleavage of APP and Tau hyperphosphorylation, further underscoring the neuroprotective effects of BYHWD in the AD model and offering novel mechanistic insights for AD intervention.